IP Library Granted Patent US 9,006,405
Granted Patent B2
US 9,006,405 · App. 13/134,121 · Granted Apr 14, 2015

Modified renilla luciferase nucleic acids and methods of use

Inventors: Nathan D. Trinklein (San Carlos, CA); Shelley Force Aldred (Hayward, CA)
Assignee: SwitchGear Genomics, Inc.
C12N9/0069C12Q1/66
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,006,405
App. No.
13/134,121
Granted
Apr 14, 2015
Kind
B2
Abstract

This invention provides modified nucleotide sequences encoding luciferase that have greater expression than wild type luciferase.

Claims (41)

1. A nucleic acid molecule comprising a reporter nucleotide sequence encoding a polypeptide comprising a Renilla luciferase amino acid sequence having at least 99% sequence identity with SEQ ID NO:1, wherein the Renilla luciferase amino acid sequence is encoded by a luciferase nucleotide sequence having at least 95% sequence identity with SEQ ID NO:2.

2. The nucleic acid molecule of claim 1 wherein the Renilla luciferase amino acid sequence is encoded by a luciferase nucleotide sequence having at least 98% sequence identity with SEQ ID NO:2.

3. The nucleic acid molecule of claim 1 wherein the Renilla luciferase amino acid sequence is encoded by a luciferase nucleotide sequence having at least 99% sequence identity with SEQ ID NO:2.

4. The nucleic acid molecule of claim 1 wherein the Renilla luciferase amino acid sequence is encoded by a luciferase nucleotide sequence having at least 99.9% sequence identity with SEQ ID NO:2.

5. The nucleic acid molecule of claim 1 wherein the Renilla luciferase amino acid sequence is encoded by a luciferase nucleotide sequence identical with SEQ ID NO:2.

6. The nucleic acid molecule of claim 1 wherein the polypeptide is Renilla luciferase (SEQ ID NO:1) (RenS).

7. The nucleic acid molecule of claim 6 wherein RenS is encoded by the nucleotide sequence of SEQ ID NO:2.

8. The nucleic acid molecule of claim 1 wherein the polypeptide is a fusion protein comprising the Renilla luciferase amino acid sequence of SEQ ID NO:1.

9. The nucleic acid molecule of claim 8 wherein the Renilla luciferase amino acid sequence is encoded by the nucleotide sequence of SEQ ID NO:2.

10. The nucleic acid molecule of claim 8 wherein the fusion protein is RenSP (SEQ ID NO: 3).

11. The nucleic acid of claim 10 wherein the RenSP is encoded by the nucleotide sequence of SEQ ID NO: 4.

12. The nucleic acid molecule of claim 8 wherein the fusion polypeptide comprises a protein destabilization domain that decreases the half-life of Renilla luciferase.

13. The nucleic acid molecule of claim 1 wherein the luciferase nucleotide sequence contains no more than 10 regulatory motifs selected from the motifs of FIG. 3 .

14. A recombinant nucleic acid comprising a promoter operably linked with a reporter nucleotide sequence, wherein the reporter nucleotide sequence encodes a polypeptide comprising a Renilla luciferase amino acid sequence having at least 99% sequence identity with SEQ ID NO:1, wherein the Renilla luciferase amino acid sequence is encoded by a luciferase nucleotide sequence having at least 95% sequence identity with SEQ ID NO:2.

15. The recombinant nucleic acid of claim 14 wherein the polypeptide comprises Renilla luciferase (SEQ ID NO:1) (RenS) encoded by a luciferase nucleotide sequence having at least 99% sequence identity with SEQ ID NO:2.

16. The recombinant nucleic acid of claim 14 wherein the Renilla Luciferase amino acid sequence is encoded by the luciferase nucleotide sequence of SEQ ID NO:2.

17. The recombinant nucleic acid of claim 14 wherein the polypeptide is RenSP (SEQ ID NO: 3).

18. The recombinant nucleic acid of claim 14 comprised in a plasmid.

19. A recombinant cell comprising a recombinant nucleic acid comprising a promoter operably linked with a reporter nucleotide sequence, wherein the reporter nucleotide sequence encodes a polypeptide comprising a Renilla luciferase amino acid sequence having at least 99% sequence identity with SEQ ID NO:1, wherein the Renilla luciferase amino acid sequence is encoded by a luciferase nucleotide sequence having at least 95% sequence identity with SEQ ID NO:2.

20. The recombinant cell of claim 19 wherein the polypeptide comprises Renilla luciferase (SEQ ID NO:1) (RenS) encoded by a luciferase nucleotide sequence having at least 99% sequence identity with SEQ ID NO:2.

21. The recombinant cell of claim 19 wherein the luciferase nucleotide sequence has at least 98% sequence identity with SEQ ID NO:2.

22. The recombinant cell of claim 19 wherein the luciferase nucleotide sequence is SEQ ID NO:2.

23. The recombinant cell of claim 19 which is a mammalian cell.

24. A kit comprising: (1) a vector containing a nucleic acid molecule comprising a reporter nucleotide sequence encoding a polypeptide comprising a Renilla luciferase amino acid sequence having at least 99% sequence identity with SEQ ID NO:1, wherein the Renilla luciferase amino acid sequence is encoded by a luciferase nucleotide sequence having at least 95% sequence identity with SEQ ID NO:2; and (2) a luciferase substrate.

25. The kit of claim 24 wherein the polypeptide comprises Renilla luciferase (SEQ ID NO:1) (RenS) encoded by a luciferase nucleotide sequence having at least 99% sequence identity with SEQ ID NO:2.

26. The kit of claim 24 wherein the luciferase nucleotide sequence has at least 98% sequence identity with SEQ ID NO:2.

27. The kit of claim 24 wherein the luciferase nucleotide sequence is SEQ ID NO:2.

28. The kit of claim 24 wherein the Luciferase substrate is coelenterazine.

29. The nucleic acid molecule of claim 1 further comprising a cloning site positioned relative to the reporter nucleotide sequence such that an expression control sequence inserted into the cloning site becomes operably linked with the luciferase-encoding nucleotide sequence.

30. The nucleic acid molecule of claim 1 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

31. The nucleic acid molecule of claim 2 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

32. The nucleic acid molecule of claim 3 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

33. The nucleic acid molecule of claim 4 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

34. The nucleic acid molecule of claim 13 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

35. The recombinant nucleic acid of claim 14 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

36. The recombinant cell of claim 19 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

37. The recombinant cell of claim 21 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

38. The recombinant cell of claim 23 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

39. The kit of claim 24 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

40. The kit of claim 26 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

41. The kit of claim 28 , wherein the Renilla luciferase amino acid sequence is SEQ ID NO:1.

Assignments (4)
SECURITY INTEREST Recorded Aug 10, 2024
From: ACTIVE MOTIF, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 068244/0975 →
CORRECTIVE ASSIGNMENT TO CORRECT THE TYPOGRAPHICAL ERROR OF A PATENT NUMBER FROM 6993823 TO 9663823 PREVIOUSLY RECORDED ON REEL 042883 FRAME 0369. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER . Recorded Aug 29, 2017
From: SWITCHGEAR GENOMICS, INC.
To: ACTIVE MOTIF, INC.
Reel/Frame 043569/0656 →
MERGER Recorded Jul 3, 2017
From: SWITCHGEAR GENOMICS, INC.
To: ACTIVE MOTIF, INC.
Reel/Frame 042883/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2011
From: TRINKLEIN, NATHAN D.; ALDRED, SHELLEY FORCE
To: SWITCHGEAR GENOMICS
Reel/Frame 026938/0032 →
Continuity (2)
Provisional Application 61397340 · Jun 10, 2010
Related Publication 20120035077A1 · Feb 9, 2012